Envoy Medical Inc
envoymedical.comWhat Do They Do?
Develops implanted hearing devices for people with hearing loss, including a middle-ear implant and an investigational cochlear implant.
10-K for FY2025, filed Mar 23, 2026We are a hearing health company focused on providing innovative medical technologies across the hearing loss spectrum. Our technologies are…View ↗
Our first product, the Esteem FI-AMEI, received FDA approval in 2010. The Esteem FI-AMEI remains the only FDA approved fully implanted…View ↗
In late 2015, we made the decision to shift our focus from the Esteem FI-AMEI to a new product that would leverage our sensor technology…View ↗
The Acclaim CI is fully implanted and does not have the need for any external component to be worn on the ear. Unlike partially implanted…View ↗
How Do They Make Money?
$241K
-
10-K for FY2025, filed Mar 23, 2026
$241K ↗
Who Are Their Customers?
The Acclaim CI is intended for adults with severe-to-profound sensorineural hearing loss. Envoy plans to reach patients through trained surgical sites, with audiologists referring candidates to those sites.
10-K for FY2025, filed Mar 23, 2026The Acclaim CI is designed to address sensorineural hearing loss that is not adequately addressed by hearing aids. As part of the clinical…View ↗
The surgical professionals believed to be best suited to implant the Acclaim CI are otologists and neurotologists (i.e., sub-specialties of…View ↗
Outside of surgical sites, there is a subset of audiologists who traditionally work with patients currently using hearing aids. These…View ↗
Do Revenues Turn Into Profits?
No. It lost $23.8M in FY2025.
10-K for FY2025, filed Mar 23, 2026
−$22.3MView ↗
10-K for FY2025, filed Mar 23, 2026
−$23.8MView ↗
10-K for FY2025, filed Mar 23, 2026
−$18.4MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 10, 2026
−$6MView ↗
- ▲ +5% (Loss)
- vs −$5.7M in Q2 FY2025
-
Mar 31, 2026
Envoy changed its independent auditor
EisnerAmper was appointed after Grant Thornton was dismissed; the prior audit reports included a going-concern paragraph.
Sources
8-K, filed Mar 31, 2026
The Audit Committee (the “Committee”) of the Board of Directors of Envoy Medical, Inc. (the “Company”) conducted a competitive process to…View ↗
From acquisition vehicle to hearing devices
The older report described a blank-check company seeking a business combination; the latest describes Envoy as a hearing-health company developing implanted hearing devices.
10-K for FY2022, filed Apr 3, 2023 10-K for FY2025, filed Mar 23, 2026We are a blank check company incorporated as a Delaware corporation on December 28, 2020 for the purpose of effecting a merger, share…View ↗
We are a hearing health company focused on providing innovative medical technologies across the hearing loss spectrum. Our technologies are…View ↗
Who Do They Compete With?
Competes with Cochlear, Advanced Bionics, Med-El, and Nurotron
10-K for FY2025, filed Mar 23, 2026There are currently three major cochlear implant manufacturers — Cochlear Ltd., Advanced Bionics (“Sonova”), and Med-El. Oticon Medical…View ↗
Loading...
